Phase I dose escalation study
Showing 1 - 25 of >10,000
Alcohol-Related Disorders Trial in Los Angeles (Dihydromyricetin)
Not yet recruiting
- Alcohol-Related Disorders
-
Los Angeles, CaliforniaUniversity of Southern California
Nov 11, 2022
Breast Cancer Trial in Dallas (Radiomics on MRI)
Recruiting
- Breast Cancer
- Radiomics on MRI
-
Dallas, TexasUniversity of Texas Southwestern Medical Center - Dallas
Nov 28, 2022
Lymphoma, Solid Tumors Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome)
Recruiting
- Lymphoma, Solid Tumors
- Mitoxantrone Hydrochloride Liposome
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 14, 2022
Breast Cancer Trial in Tampa (Eribulin, Carboplatin)
Completed
- Breast Cancer
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Oct 28, 2022
Ovarian Cancer Trial in Lexington (Lapatinib and Paclitaxel)
Recruiting
- Ovarian Cancer
- Lapatinib and Paclitaxel
-
Lexington, KentuckyMarkey Cancer Center
Dec 2, 2022
Advanced Solid Tumor Trial in Nijmegen (PRECIOUS-01)
Recruiting
- Advanced Solid Tumor
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Oct 26, 2022
Solid Tumor, Adult Trial (CF33-CD19 IT, CF33-CD19 IV, Blinatumomab)
Not yet recruiting
- Solid Tumor, Adult
- CF33-CD19 IT
- +2 more
- (no location specified)
Sep 26, 2023
Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma Trial in Shanghai (Phase I
Not yet recruiting
- Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma
- Phase I dose escalation
- +3 more
-
Shanghai, Shanghai, ChinaFudan Cancer Hospital
Apr 24, 2023
Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)
Active, not recruiting
- Astrocytoma, Grade IV
- +3 more
- Radiation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Prostatic Tumors, Castration-Resistant Trial in Rotterdam (Radionuclide Therapy)
Recruiting
- Prostatic Neoplasms, Castration-Resistant
- Radionuclide Therapy
-
Rotterdam, Zuid-Holland, NetherlandsErasmus Medical Center
Jun 5, 2023
Solid Tumors Trial (BI 1821736)
Not yet recruiting
- Solid Tumors
- BI 1821736
- (no location specified)
Apr 21, 2023
Metastatic Castration-resistant Prostate Cancer Trial (HP518 - Dose Escalation, HP518 -Dose Expansion)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- HP518 - Dose Escalation
- HP518 -Dose Expansion
- (no location specified)
Dec 1, 2023
Systemic Lupus Erythematosus Trial in Shanghai (Relma-cel)
Recruiting
- Systemic Lupus Erythematosus
- Relma-cel
-
Shanghai, ChinaRelma-cel Medical
Mar 12, 2023
Cytomegalovirus Infections, Solid Organ Transplant Trial in Madison (CMV specific T-cells)
Recruiting
- Cytomegalovirus Infections
- Solid Organ Transplant
- CMV specific T-cells
-
Madison, WisconsinUniversity of Wisconsin School of Medicine and Public Health
Nov 14, 2022
Prostate Cancer Trial in New Orleans, New York (225Ac-J591)
Active, not recruiting
- Prostate Cancer
-
New Orleans, Louisiana
- +1 more
Nov 15, 2022
Birch Pollen Allergy Trial in Mississauga (DM-101PX, Placebo to Match DM-101PX)
Recruiting
- Birch Pollen Allergy
- DM-101PX
- Placebo to Match DM-101PX
-
Mississauga, Ontario, CanadaCliantha Research
Sep 18, 2023
Solid Tumor Trial in Shanghai (LB4330)
Recruiting
- Solid Tumor
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 31, 2023
Advanced Solid Tumor Trial in Beijing (Simmitinib)
Recruiting
- Advanced Solid Tumor
-
Beijing, ChinaCSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Jun 2, 2022
Brain Metastases Trial in Birmingham (Dose Escalated Five Fraction Stereotactic Radiosurgery)
Recruiting
- Brain Metastases
- Dose Escalated Five Fraction Stereotactic Radiosurgery
-
Birmingham, AlabamaHazelrig-Salter Radiation Oncology Center
Mar 25, 2022
Multiple Myeloma Trial in New York (drug, biological, procedure)
Active, not recruiting
- Multiple Myeloma
- busulfan
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 3, 2023